S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

实时更新: Agentix Corp. [AGTX]

交易所: PNK 工业: Biotechnology
最后更新时间21 Mar 2024 @ 23:24

0.00% $ 0.0322

Live Chart Being Loaded With Signals

Commentary (21 Mar 2024 @ 23:24):

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of therapeutics to treat metabolic diseases. Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases...

Stats
今日成交量 1 256.00
平均成交量 1 275.00
市值 1.29M
EPS $0 ( 2024-02-14 )
下一个收益日期 ( $0 ) 2024-07-13
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -1.070
ATR14 $0 (0.00%)
Insider Trading
Date Person Action Amount type
2020-03-29 Puzzo Thomas E Sell 0 Common stock
2020-03-29 Grays Peak Ventures Llc Buy 767 000 Common stock
2020-02-24 Grays Peak Ventures Llc Buy 1 407 000 Common stock
2020-03-29 Winterhalter Michael Buy 150 000 Common stock
2019-11-22 Winterhalter Michael Sell 10 015 Common stock
INSIDER POWER
0.00
Last 33 transactions
Buy: 2 367 428 | Sell: 197 872

Agentix Corp. 相关性

10 最正相关
10 最负相关

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Agentix Corp. 财务报表

Annual 2023
营收: $0
毛利润: $0 (0.00 %)
EPS: $-0.0350
FY 2023
营收: $0
毛利润: $0 (0.00 %)
EPS: $-0.0350
FY 2022
营收: $1 240.00
毛利润: $679.00 (54.76 %)
EPS: $-0.0386
FY 2020
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.106

Financial Reports:

No articles found.

Agentix Corp.

Agentix Corp., a clinical development stage company, focuses on the development and commercialization of therapeutics to treat metabolic diseases. Its product pipeline includes AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was incorporated in 2013 and is based in Dana Point, California.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。